Blog

Agilent in Genomics

We are entering an exciting era in the advancement of human health. New technologies and a greater understanding of disease are driving

A Key to Disease Research: Post-Translational Modifications

Scientists who study diseases are increasingly looking at post-translational modifications in proteins. What are these?  Let’s take a step back and define some terms.

COVID-19: COA FS Could Be An Effective Cure—Dr Smauel Ato Duncan

As the scientific community scrambles to find a drug that can effectively treat patients sickened by a new respiratory virus, coronavirus (COVID-19),

Excitement around hydroxychloroquine for treating COVID-19

Abstract Aim: Chloroquine is an antimalarial drug used in the treatment of Plasmodium vivax malaria. Three methods to quantify chloroquine and its metabolite in

Analysis of 27 GC-Amenable Pesticides in Cannabis in North America with the 8890/7010

In the United States, Canada, and other regions where medicinal or adult recreational cannabis use has been legalized, regulatory agencies require chemical

Charge Variant and Aggregation Analysis of Innovator and Biosimilars of Rituximab

Introduction Monoclonal antibody (mAb) drugs are one of the fastest-growing biotherapeutics in the pharma market. The majority of mAbs are for the

A Key to Disease Research: Post-Translational Modifications

Scientists who study diseases are increasingly looking at post-translational modifications in proteins. What are these?  Let’s take a step back and define some terms.

TOR set to declare dividend by 2020

Managing Director of the Tema Oil Refinery (TOR) says the company has put in place stringent measures which will start yielding results

Randox Laboratories One Net Business

Connect Telecom is delighted to announce our latest One Net Business customer, Randox Laboratories. This initial 5 premises deal is our biggest